Compare McKesson Corporation (MCK) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Zoom Video Communications, Inc. — how do they compare? McKesson Corporation trades at $828.48 (market cap $97.35B), while Zoom Video Communications, Inc. trades at $90.51 (market cap $26.66B). The key difference: McKesson Corporation is far larger — about 3.7× Zoom Video Communications, Inc.'s market cap, and McKesson Corporation pays a 0.39% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| MCK | ZM | |
|---|---|---|
Market Cap | $97.35B | $26.66B |
Sector | Health | Technology |
52-Week High | $995.69 | $111.88 |
52-Week Low | $659.01 | $69.77 |
Enterprise Value | $101.98B | $19.00B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Zoom Communications (ZM) trades at $91.04, down 0.1% on the day, with a bullish technical signal from moving averages and support at $90. The company reported Q1 2026 EPS of $1.55, beating expectations, and maintains strong profitability with a net income margin of 42.0%. Recent news highlights AI product launches and a $1 billion buyback authorization, while analyst consensus price target sits at $118.79.
The outlook for ZM is cautiously optimistic, with upside potential driven by AI integration and solid cash flow, but risks include competitive pressure from Microsoft and Google, insider selling, and fluctuating cash flow trends. Wall Street sentiment is mixed, with 39% of analysts rating it Buy amid moderate growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
